Factor V Leiden: Difference between revisions
Farmersj333 (talk | contribs) (Created page with "==Background== *Also known as Factor V Leiden Deficiency or FVL *Point mutation in FV making it resistant to cleavage by activated protein C *Increased risk of thrombosis *Mos...") |
Elcatracho (talk | contribs) |
||
| (6 intermediate revisions by 2 users not shown) | |||
| Line 6: | Line 6: | ||
==Clinical Features== | ==Clinical Features== | ||
* | *Family history of thrombophilia | ||
*VTE at a young age | *VTE at a young age | ||
*VTE in an atypical location | *VTE in an atypical location | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
{{Increased clotting DDX}} | |||
==Evaluation== | ==Evaluation== | ||
| Line 32: | Line 32: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
[[Category:Heme/Onc]] | |||
Latest revision as of 05:15, 25 January 2021
Background
- Also known as Factor V Leiden Deficiency or FVL
- Point mutation in FV making it resistant to cleavage by activated protein C
- Increased risk of thrombosis
- Most individuals with FVL will never have a venous thromboembolism (VTE)
Clinical Features
- Family history of thrombophilia
- VTE at a young age
- VTE in an atypical location